225 related articles for article (PubMed ID: 34535684)
41. Barx2 and Pax7 have antagonistic functions in regulation of wnt signaling and satellite cell differentiation.
Zhuang L; Hulin JA; Gromova A; Tran Nguyen TD; Yu RT; Liddle C; Downes M; Evans RM; Makarenkova HP; Meech R
Stem Cells; 2014 Jun; 32(6):1661-73. PubMed ID: 24753152
[TBL] [Abstract][Full Text] [Related]
42. Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway.
White ES; Sagana RL; Booth AJ; Yan M; Cornett AM; Bloomheart CA; Tsui JL; Wilke CA; Moore BB; Ritzenthaler JD; Roman J; Muro AF
Exp Cell Res; 2010 Oct; 316(16):2644-53. PubMed ID: 20615404
[TBL] [Abstract][Full Text] [Related]
43. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.
Fernandez K; Serinagaoglu Y; Hammond S; Martin LT; Martin PT
Am J Pathol; 2010 Jan; 176(1):416-34. PubMed ID: 20019182
[TBL] [Abstract][Full Text] [Related]
44. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.
Searcy MB; Larsen RK; Stevens BT; Zhang Y; Jin H; Drummond CJ; Langdon CG; Gadek KE; Vuong K; Reed KB; Garcia MR; Xu B; Kimbrough DW; Adkins GE; Djekidel N; Porter SN; Schreiner PA; Pruett-Miller SM; Abraham BJ; Rehg JE; Hatley ME
Nat Commun; 2023 Nov; 14(1):7291. PubMed ID: 37968277
[TBL] [Abstract][Full Text] [Related]
45. Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
Wang L; Xiong H; Wu F; Zhang Y; Wang J; Zhao L; Guo X; Chang LJ; Zhang Y; You MJ; Koochekpour S; Saleem M; Huang H; Lu J; Deng Y
Cell Rep; 2014 Sep; 8(5):1461-74. PubMed ID: 25176644
[TBL] [Abstract][Full Text] [Related]
46. Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma.
Kovach AR; Oristian KM; Kirsch DG; Bentley RC; Cheng C; Chen X; Chen PH; Chi JA; Linardic CM
Mol Oncol; 2022 Oct; 16(20):3587-3605. PubMed ID: 36037042
[TBL] [Abstract][Full Text] [Related]
47. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
48. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
49. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
50. A rapid one-generation genetic screen in a Drosophila model to capture rhabdomyosarcoma effectors and therapeutic targets.
Galindo KA; Endicott TR; Avirneni-Vadlamudi U; Galindo RL
G3 (Bethesda); 2014 Dec; 5(2):205-17. PubMed ID: 25491943
[TBL] [Abstract][Full Text] [Related]
51. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.
Olanich ME; Sun W; Hewitt SM; Abdullaev Z; Pack SD; Barr FG
Clin Cancer Res; 2015 Nov; 21(21):4947-59. PubMed ID: 25810375
[TBL] [Abstract][Full Text] [Related]
52. Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models.
Kahsay A; Rodriguez-Marquez E; López-Pérez A; Hörnblad A; von Hofsten J
Sci Rep; 2022 Oct; 12(1):17149. PubMed ID: 36229514
[TBL] [Abstract][Full Text] [Related]
53. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs.
Soleimani VD; Punch VG; Kawabe Y; Jones AE; Palidwor GA; Porter CJ; Cross JW; Carvajal JJ; Kockx CE; van IJcken WF; Perkins TJ; Rigby PW; Grosveld F; Rudnicki MA
Dev Cell; 2012 Jun; 22(6):1208-20. PubMed ID: 22609161
[TBL] [Abstract][Full Text] [Related]
55. PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation.
Seront E; Pinto A; Bouzin C; Bertrand L; Machiels JP; Feron O
Br J Cancer; 2013 Sep; 109(6):1586-92. PubMed ID: 23989949
[TBL] [Abstract][Full Text] [Related]
56. [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR].
Chang B; Yin BM; Li F; Li XX; Lu TC; Hu WH; Jiang JF; Shi DR
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1336-8. PubMed ID: 12930690
[TBL] [Abstract][Full Text] [Related]
57. Human rhabdomyosarcoma cells express functional erythropoietin receptor: Potential therapeutic implications.
Poniewierska-Baran A; Suszynska M; Sun W; Abdelbaset-Ismail A; Schneider G; Barr FG; Ratajczak MZ
Int J Oncol; 2015 Nov; 47(5):1989-97. PubMed ID: 26412593
[TBL] [Abstract][Full Text] [Related]
58. Signals of Ezh2, Src, and Akt Involve in myostatin-Pax7 pathways regulating the myogenic fate determination during the sheep myoblast proliferation and differentiation.
Wei C; Ren H; Xu L; Li L; Liu R; Zhang L; Zhao F; Lu J; Zhang X; Du L
PLoS One; 2015; 10(3):e0120956. PubMed ID: 25811841
[TBL] [Abstract][Full Text] [Related]
59. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract][Full Text] [Related]
60. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
